328 related articles for article (PubMed ID: 2406716)
21. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines.
Choo KB; Chong KY; Chou HF; Liew LN; Liou CC
Biochem Biophys Res Commun; 1989 Jan; 158(1):334-40. PubMed ID: 2463837
[TBL] [Abstract][Full Text] [Related]
23. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
24. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
[TBL] [Abstract][Full Text] [Related]
25. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
26. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
27. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
28. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.
Reed JC; Cuddy M; Haldar S; Croce C; Nowell P; Makover D; Bradley K
Proc Natl Acad Sci U S A; 1990 May; 87(10):3660-4. PubMed ID: 1692620
[TBL] [Abstract][Full Text] [Related]
29. Activation of c-Ki-ras coexists with c-myc amplification in cells from a nude mouse tumor induced by the human breast carcinoma cell line SW 613-S.
Carloni G; Champ B; Vilarem MJ; Lavialle C; Cassingena R
FEBS Lett; 1988 Jun; 233(2):268-72. PubMed ID: 3289968
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
31. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
32. Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.
Hurlin PJ; Maher VM; McCormick JJ
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):187-91. PubMed ID: 2643097
[TBL] [Abstract][Full Text] [Related]
33. Detection and cloning of potent transforming gene(s) from chewing tobacco-related human oral carcinomas.
Saranath D; Bhoite LT; Deo MG; Tandle AT; D'Costa J; Kolhapure RN; Govardhan MK; Banerjee K
Eur J Cancer B Oral Oncol; 1994 Jul; 30B(4):268-77. PubMed ID: 7950842
[TBL] [Abstract][Full Text] [Related]
34. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
[TBL] [Abstract][Full Text] [Related]
35. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
Kurie JM; Morse HC; Principato MA; Wax JS; Troppmair J; Rapp UR; Potter M; Mushinski JF
Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
[TBL] [Abstract][Full Text] [Related]
36. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
Xin B; Yamamoto M; Fujii K; Ooshio T; Chen X; Okada Y; Watanabe K; Miyokawa N; Furukawa H; Nishikawa Y
Oncogene; 2017 Sep; 36(36):5087-5097. PubMed ID: 28481866
[TBL] [Abstract][Full Text] [Related]
37. Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.
Pfeifer AM; Jones RT; Bowden PE; Mann D; Spillare E; Klein-Szanto AJ; Trump BF; Harris CC
Cancer Res; 1991 Jul; 51(14):3793-801. PubMed ID: 1712250
[TBL] [Abstract][Full Text] [Related]
38. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
39. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
40. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
